Capital Fund Management S.A. Eli Lilly & CO Call Options Transaction History

Capital Fund Management S.A.

$36 Billion
Q3 2024

Call Options

28 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	SELL	$772.14 - $960.02 $17.3 Million - $21.5 Million	-22,400 Reduced 11.71%	168,900 $150 Million
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $31.3 Million - $39.3 Million	-43,200 Reduced 18.42%	191,300 $173 Million
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $34.1 Million - $45.6 Million	-57,500 Reduced 19.69%	234,500 $182 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $73.1 Million - $86.1 Million	139,100 Added 90.97%	292,000 $170 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $32.6 Million - $44.9 Million	74,900 Added 96.03%	152,900 $82.1 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $9.65 Million - $12.9 Million	-27,500 Reduced 26.07%	78,000 $36.6 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $21.2 Million - $24.9 Million	68,300 Added 183.6%	105,500 $36.2 Million
Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $17.6 Million - $20.5 Million	-54,800 Reduced 59.57%	37,200 $13.6 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $20.6 Million - $23.5 Million	69,500 Added 308.89%	92,000 $29.7 Billion
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $1.64 Million - $1.93 Million	-5,900 Reduced 20.77%	22,500 $7.3 Million
Q1 2022 May 12, 2022	SELL	$234.69 - $291.66 $13.4 Million - $16.7 Million	-57,200 Reduced 66.82%	28,400 $8.13 Million
Q4 2021 Feb 10, 2022	BUY	$224.85 - $279.04 $674,550 - $837,120	3,000 Added 3.63%	85,600 $23.6 Million
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $12.1 Million - $14.9 Million	54,800 Added 197.12%	82,600 $19.1 Million
Q2 2021 Aug 12, 2021	SELL	$180.55 - $233.54 $54,165 - $70,062	-300 Reduced 1.07%	27,800 $6.38 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $1.13 Million - $1.47 Million	6,900 Added 32.55%	28,100 $5.25 Million
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $745,722 - $862,563	-5,100 Reduced 19.39%	21,200 $3.14 Million
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $19.6 Million - $23.6 Million	-143,900 Reduced 84.55%	26,300 $4.32 Million
Q1 2020 May 13, 2020	BUY	$119.05 - $147.35 $8.14 Million - $10.1 Million	68,400 Added 67.19%	170,200 $23.6 Million
Q4 2019 Feb 13, 2020	BUY	$106.92 - $132.43 $4.8 Million - $5.95 Million	44,900 Added 78.91%	101,800 $13.4 Million
Q3 2019 Nov 13, 2019	BUY	$106.79 - $116.16 $2.34 Million - $2.54 Million	21,900 Added 62.57%	56,900 $6.36 Million
Q2 2019 Aug 12, 2019	SELL	$110.79 - $129.32 $14.8 Million - $17.2 Million	-133,300 Reduced 79.2%	35,000 $3.88 Million
Q1 2019 May 13, 2019	BUY	$111.31 - $131.02 $3.09 Million - $3.64 Million	27,800 Added 19.79%	168,300 $21.8 Million
Q4 2018 Feb 13, 2019	BUY	$105.9 - $118.64 $9.88 Million - $11.1 Million	93,300 Added 197.67%	140,500 $16.3 Million
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $3.75 Million - $4.69 Million	43,700 Added 1248.57%	47,200 $5.07 Million
Q2 2018 Aug 14, 2018	SELL	$75.7 - $86.88 $264,950 - $304,080	-3,500 Reduced 50.0%	3,500 $299,000
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $2.14 Million - $2.52 Million	-28,800 Reduced 80.45%	7,000 $542,000
Q4 2017 Feb 09, 2018	BUY	$81.94 - $87.89 $2.61 Million - $2.79 Million	31,800 Added 795.0%	35,800 $3.02 Million
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $308,280 - $342,160	4,000	4,000 $342,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

Lilly Endowment Inc Indianapolis, IN

96.9M
Shares

$74.4 Billion
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

73.8M
Shares

$56.6 Billion
1.2% of portfolio
Black Rock Inc. New York, NY

65.9M
Shares

$50.6 Billion
1.37% of portfolio
Pnc Financial Services Group, Inc. Pittsburgh, PA

51.4M
Shares

$39.4 Billion
29.2% of portfolio
State Street Corp Boston, MA

33.9M
Shares

$26 Billion
1.24% of portfolio

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.

Account